2 Drug Developers Latest To Tap Market With $275M On Offer
GlycoMimetics Inc. and Egalet Corp. filed for follow-on offerings Tuesday looking to raise a total of $275 million to fund further drug development becoming the latest of several drug developers that...To view the full article, register now.
Already a subscriber? Click here to view full article